Lifelong Learning in Oncology

At Johnson & Johnson, our focus is singular—eliminate cancer.

We listen and learn with compassion to understand the needs of patients, caregivers, and healthcare professionals who remind us every day why we are working toward this bold ambition.

Cancer remains a leading cause of death globally. In 2022 alone, 20 million people worldwide were diagnosed with cancer, and almost 10 million died of the disease. With more than a three-decade legacy in oncology innovation, our commitment to pioneer new therapeutic advances for patients with cancer has never been stronger.